95 patient evaluations for Levetiracetam
Sort by:
Most recent
Oct 21, 2009 (Started Apr 01, 2003)
-
EffectivenessModerate (for nerve pain (neuralgia))
-
Side effectsNone
-
AdherenceAlways
-
BurdenA little hard to take
Dosage:
4500 mg
Daily
- 0 helpful marks
Nov 9, 2008 (Started Sep 03, 2007)
-
EffectivenessCan't tell (for epilepsy)
-
Side effectsNone
-
AdherenceNever taken as prescribed
-
BurdenVery hard to take
Advice & Tips:
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.
Cost:
$50-99 monthly
Side effects:
balance problems, eyes wander out of sync, glaucoma (both eyes)
Nov 9, 2007 (Started Sep 03, 2007)
-
EffectivenessCan't tell (for epilepsy)
-
Side effectsSevere (balance problems, eyes wander out of sync)
-
AdherenceAlways
-
BurdenNot at all hard to take
Dosage:
500 mg
Daily
Advice & Tips:
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.
Cost:
$50-99 monthly
Side effects:
balance problems, eyes wander out of sync, glaucoma (both eyes)
Nov 8, 2007 (Started Sep 03, 2007)
-
EffectivenessCan't tell (for epilepsy)
-
Side effectsSevere (balance problems)
-
AdherenceAlways
-
BurdenVery hard to take
Dosage:
100 mg
Daily
Advice & Tips:
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.
Cost:
$50-99 monthly
Side effects:
balance problems, eyes wander out of sync, glaucoma (both eyes)
- 0 helpful marks
Sep 9, 2008 (Started Apr 01, 2007)
-
EffectivenessMajor (for Other)
-
Side effectsModerate (decreased appetite, sleepiness)
-
AdherenceAlways
-
BurdenNot at all hard to take
Dosage:
1000 mg
Daily
Advice & Tips:
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.
Side effects:
sleepiness, decreased appetite
- 0 helpful marks
Last updated:
Showing 3 of 95 patient evaluations for Levetiracetam